Compounds > bisucaberin
Page last updated: 2024-12-08

bisucaberin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bisucaberin: structure given in first source; isolated from broth of Alteromonas haloplanktis SB-1123 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID133971
CHEBI ID177848
SCHEMBL ID10574088
MeSH IDM0154680

Synonyms (18)

Synonym
1,6,12,17-tetraazacyclodocosane-2,5,13,16-tetrone, 6,17-dihydroxy-
3py4b0e1h1 ,
unii-3py4b0e1h1
CHEBI:177848
1,12-dihydroxy-1,6,12,17-tetrazacyclodocosane-2,5,13,16-tetrone
1,12-dihydroxy-1,6,12,17-tetraazacyclodocosane-2,5,13,16-tetrone
112972-60-8
nsc-619796
nsc619796
from alteromonas haloplanktis sb-1123
bisucaberin
1,12-dihydroxy-1,6,12,17tetraaza-cyclodocosane-2,5,13,16-tetraone
SCHEMBL10574088
DTXSID10150242
1,6,12,17-tetraazacyclodocosane-2,5,13,16-tetrone, 1,12-dihydroxy-
OX8 ,
1,12-bis(oxidanyl)-1,6,12,17-tetrazacyclodocosane-2,5,13,16-tetrone
AKOS040756226
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
keratan 6'-sulfateA keratan sulfate with random sulfation at the 6'-position.
azamacrocycleA cyclic macromolecule containing one or more nitrogen atoms in place of carbon either as the divalent group NH for the group CH2 or a single trivalent nitrogen atom for the group CH.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
bisucaberin biosynthesis315

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (18.18)18.7374
1990's0 (0.00)18.2507
2000's2 (18.18)29.6817
2010's6 (54.55)24.3611
2020's1 (9.09)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.70

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.70 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.89 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.70)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
cadaverine
[no description available]		7.4820alkane-alpha,omega-diamineDaphnia magna metabolite;
Escherichia coli metabolite;
mouse metabolite;
plant metabolite
putrescine
[no description available]		3.0640alkane-alpha,omega-diamineantioxidant;
fundamental metabolite
deferoxamine
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.. desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.		2.0810acyclic desferrioxaminebacterial metabolite;
ferroptosis inhibitor;
iron chelator;
siderophore
1,6-diaminohexane
1,6-diaminohexane: Russian drug; RN given refers to parent cpd; structure. hexane-1,6-diamine : A C6 alkane-alpha,omega-diamine.		2.5820alkane-alpha,omega-diaminehuman xenobiotic metabolite
molybdenum
Molybdenum: A metallic element with the atomic symbol Mo, atomic number 42, and atomic weight 95.95. It is an essential trace element, being a component of the enzymes xanthine oxidase, aldehyde oxidase, and nitrate reductase.		7.1310chromium group element atommicronutrient
chromium
Chromium: A trace element that plays a role in glucose metabolism. It has the atomic symbol Cr, atomic number 24, and atomic weight 52. According to the Fourth Annual Report on Carcinogens (NTP85-002,1985), chromium and some of its compounds have been listed as known carcinogens.. chromium ion : An chromium atom having a net electric charge.. chromium atom : A chromium group element atom that has atomic number 24.		7.1310chromium group element atom;
metal allergen		micronutrient
1,4-diaminobutanone
1,4-diaminobutanone: RN given refers to parent cpd		2.1310
alcaligin
alcaligin: a siderophore produced by Bordetella & Alcaligenes sp.; structure given in first source		2.110cyclic hydroxamic acid
putrebactin
putrebactin: an iron-chelating agent isolated from Shewanella putrefaciens; structure in first source		8.0640cyclic hydroxamic acid
avaroferrin
avaroferrin: a siderophore isolated from Shewanella algae; structure in first source		7.8730
ConditionIndicatedRelationship StrengthStudiesTrials
Fish Diseases
Diseases of freshwater, marine, hatchery or aquarium fish. This term includes diseases of both teleosts (true fish) and elasmobranchs (sharks, rays and skates).		02.0110
Infections, Vibrio
[description not available]		02.0110